GSK-3 inhibitors (Tel Aviv University/Weizmann Institute)

N/A

Report date: 2025/01/26 17:28:41

Base Information

Drug NameGSK-3 inhibitors (Tel Aviv University/Weizmann Institute)
Drug Alias NameGSK-3 inhibitors (Tel Aviv University)L-803mtsGSC-7
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlycogen synthase kinase-3 degraders
TargetsGlycogen synthase kinase-3
Therapy Area/IndicationsDiabetes MellitusCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesWeizmann Institute Of ScienceRamot At Tel Aviv UniversityTel Aviv University
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A